TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | – | 1,302 | +2356.6% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 53 | -84.5% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 342 | +71.0% | 0.00% | – |
| Q4 2017 | $1,000 | -97.0% | 200 | -95.8% | 0.00% | – |
| Q3 2017 | $33,000 | +1550.0% | 4,807 | +1289.3% | 0.00% | – |
| Q2 2017 | $2,000 | -85.7% | 346 | -76.8% | 0.00% | – |
| Q1 2017 | $14,000 | +27.3% | 1,494 | -45.7% | 0.00% | – |
| Q4 2016 | $11,000 | +1000.0% | 2,751 | +1577.4% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 164 | +51.9% | 0.00% | – |
| Q3 2015 | $1,000 | -98.3% | 108 | -91.2% | 0.00% | – |
| Q2 2015 | $58,000 | +2800.0% | 1,227 | +513.5% | 0.00% | – |
| Q1 2014 | $2,000 | -33.3% | 200 | -13.4% | 0.00% | – |
| Q3 2013 | $3,000 | – | 231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |